ALL CUSTOMERS: Read ‘HOW TO ORDER’ before placing an order


Below is a list of various cannabis and medical ailments studies from Universities, Medical Institutes, Government departments that help create our cannabis recommendations of cannas types, methods of delivery, and dosage.

University of Michigan: Journal of Pain Study

It was shown in 2016 that cannabis use was associated with:

  • 64% lower opioid use in patients with chronic pain.
  • fewer medication side effects and medications used.
  • better quality of life in patients with chronic pain.

The National Academies of Science, Engineering and Medicine

Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (2017) found that “there is substantial evidence that cannabis is an effective treatment for chronic pain in adults

University of Michigan Medical School: Professor Of Pain Management Anaesthesiology

“We are learning that the higher the dose of opioids people are taking, the higher the risk of death from overdose,” said Dr. Daniel Clauw

Harvard University

Harvard University (2015) led a review of 28 studies examining the efficacy of cannabinoids to treat various pain and medical issues. Six out of six general chronic pain studies and five out of five neuropathic pain studies found a significant improvement in symptoms among patients. Two examined an oral spray preparation. Author quote” “Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high quality evidence.”

San Francisco General Hospital: Chief of Hematology/Oncology

Professor Dr. Donald Abrams, supports cannabis to treat chronic pain ““Given the safety profile of cannabis compared to opioids, cannabis appears to be far safer.”

The Institute of Medicine

In 1999, the institute of medicine issued an evidence-based report on medical marijuana. It listed conditions that may be helped by cannabinoids, including neuropathic pain, acute pain, spinal cord injury, post operative pain, cancer pain, multiple sclerosis, nausea and appetite control among others.

The IOM found that cannabinoids are capable of giving mild to moderate pain relief comparable to codeine. In one study cited in the report,10 milligrams of THC  yielded the same amount of pain relief as 60 milligrams of codeine. Side effects were similar with both drugs, but the THC seemed to be more sedating than the codeine. The patients taking the THC reported a greater sense of well-being and less anxiety.

FDA Clinical Trials

Several FDA designed clinical trials show that inhaled cannabis can significantly alleviate neuropathic pain.

McGill University

McGill University study (2010)reported that smoked cannabis significantly improved measures of pain, sleep quality and anxiety in participants with refractory chronic pain for which conventional therapies had failed.

College of Family Physicians of Canada

In 2014, the college recommended that patients with chronic pain smoke cannabis. It stated that patients with severe neuropathic pain conditions could find relief in cannabis if they had not had adequate responses to other medications.

Canadian Medical Association Journal

The Canadian Medical Association Journalfound that cannabis could help reduce chronic pain in men and women. The 21 chronic nerve pain subjects were administered three different marijuana potencies at different times during the study. The strengths were rotated with a placebo, and none of the subjects knew what they were taking at any given point during the study. The results was reduction in pain by patients who took the highest potency of cannabis tested.

Studies On Potency

Potency can also vary depending on the cannabis plant which is affected by certain factors such as soil conditions, climates, temperature, and humidity for growing the plant. Plants that are grown outdoors usually have less potency compared to those grown indoors under a controlled process. The potency of the extracts is important as patients would have to use fewer products to get the required result needed.

Studies on Cannabis Topicals

Existing research has focused on their potential for treating inflammation, pain and uncomfortable skin conditions (such as psoriasis and dermatitis).

study on THC’s use for allergic inflammation out of the University of Bonn’s Department of Dermatology and Allergy concluded that cannabinoids should be “harnessed …for the treatment of inflammatory skin diseases.”

2009 study published in the journal Experimental Dermatology found that cannabinoids “seem to have immunosuppressive properties and could be considered as potential anti-inflammatory drugs.”

Additionally, the researchers concluded that topically administered cannabis has potential for its antipruritic (anti-itching) effect and pain relief.